Bilcare Ltd

Bilcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bilcare Ltd

₹ 64.4 3.55%
01 Jun - close price
bilcare-group.com BSE: 526853 NSE: BI
About

Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).

Key Points

Bilcare Resolution Update[1]
Company had been in default since 2013 and was admitted to NCLT proceedings in 2019. In 2023, it settled its dues through a one-time settlement, wherein Caprihans India Ltd.It's subsidiary leveraged its balance sheet to acquire compay's operating assets, enabling company to repay its lenders.

Website BSE NSE
  • Market Cap ₹ 152 Cr.
  • Current Price ₹ 64.4
  • High / Low ₹ 116 / 50.0
  • Stock P/E 27.5
  • Book Value ₹ 83.6
  • Dividend Yield 0.00 %
  • ROCE 5.56 %
  • ROE 1.66 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.77 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 3.33% over past five years.
  • Promoter holding is low: 30.0%
  • Company has a low return on equity of -4.07% over last 3 years.
  • Contingent liabilities of Rs.727 Cr.
  • Earnings include an other income of Rs.26.2 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Research, Analytics & Technology

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
233.59 182.25 189.92 174.94 200.07 194.14 201.74 198.13 194.03 186.36 178.20 181.32 187.66
219.16 168.79 173.22 157.69 208.33 175.20 194.09 187.47 186.35 175.29 174.78 168.31 170.73
Operating Profit 14.43 13.46 16.70 17.25 -8.26 18.94 7.65 10.66 7.68 11.07 3.42 13.01 16.93
OPM % 6.18% 7.39% 8.79% 9.86% -4.13% 9.76% 3.79% 5.38% 3.96% 5.94% 1.92% 7.18% 9.02%
231.29 2.75 0.56 3.76 8.82 3.74 -6.02 -6.47 21.16 6.08 4.32 3.34 12.46
Interest 11.38 19.00 19.66 20.54 22.59 20.85 23.68 19.48 18.68 18.55 19.06 17.04 17.69
Depreciation 9.30 10.50 10.48 10.57 13.40 11.52 11.04 11.74 4.66 11.56 12.23 5.01 4.78
Profit before tax 225.04 -13.29 -12.88 -10.10 -35.43 -9.69 -33.09 -27.03 5.50 -12.96 -23.55 -5.70 6.92
Tax % 65.22% -1.13% -5.36% 34.06% -44.48% 55.01% -9.55% -39.92% -119.27% -24.69% -0.98% 3.33% -13.44%
78.28 -13.14 -12.19 -13.54 -19.67 -15.02 -29.93 -16.24 12.06 -9.76 -23.32 -5.89 7.85
EPS in Rs 19.63 -3.36 -3.22 -2.91 -4.63 -2.71 -6.81 -3.04 7.47 -1.61 -5.25 0.41 5.68
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
2,692 2,603 2,633 2,778 2,997 1,827 623 845 982 747 788 734
2,506 2,396 2,443 2,617 2,827 1,782 572 784 925 708 743 689
Operating Profit 186 207 190 161 170 45 51 60 57 39 45 44
OPM % 7% 8% 7% 6% 6% 2% 8% 7% 6% 5% 6% 6%
9 -87 107 297 59 254 45 44 237 16 12 26
Interest 236 151 176 249 283 174 76 69 60 82 82 72
Depreciation 191 164 177 416 378 239 46 39 38 45 46 20
Profit before tax -232 -194 -56 -207 -433 -114 -25 -4 196 -72 -71 -21
Tax % -7% -58% 42% -4% 5% -13% -55% 3% 74% -18% -21% -19%
-216 -82 -80 -199 -453 -99 -11 -4 50 -59 -56 -17
EPS in Rs -91.76 -36.04 -35.91 -85.43 -193.28 -43.97 -8.95 -5.35 6.39 -14.12 -12.23 0.73
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -12%
5 Years: 3%
3 Years: -9%
TTM: -7%
Compounded Profit Growth
10 Years: -9%
5 Years: 16%
3 Years: 37%
TTM: 120%
Stock Price CAGR
10 Years: 4%
5 Years: 3%
3 Years: 11%
1 Year: -22%
Return on Equity
10 Years: -46%
5 Years: -6%
3 Years: -4%
Last Year: 2%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 24 24 24 24 24 24 24 24 24 24 24 24
Reserves 1,073 689 590 376 -93 85 63 52 507 474 445 173
2,311 2,122 2,014 2,089 2,270 707 677 690 639 756 682 620
933 786 830 913 888 297 300 362 424 314 266 26
Total Liabilities 4,340 3,620 3,457 3,402 3,087 1,112 1,064 1,127 1,593 1,568 1,417 843
1,926 2,432 2,403 2,180 2,005 534 494 465 1,045 1,038 949 433
CWIP 218 161 149 170 79 0 0 1 1 1 4 8
Investments 0 1 0 1 0 0 0 0 2 8 11 14
2,196 1,026 904 1,051 1,003 577 570 661 545 521 453 387
Total Assets 4,340 3,620 3,457 3,402 3,087 1,112 1,064 1,127 1,593 1,568 1,417 843

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-315 177 300 98 206 256 72 41 -7 62 85
247 -358 -129 -203 -104 1,309 2 -4 36 -106 81
119 149 -155 91 -103 -1,600 -83 -55 -19 36 -169
Net Cash Flow 50 -32 16 -13 -1 -35 -9 -18 10 -7 -3
Free Cash Flow -74 -12 165 -115 91 1,569 69 37 11 -34 140
CFO/OP -170% 85% 173% 75% 148% 828% 141% 78% -6% 162% 193%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 125 35 29 38 38 22 90 95 70 73 55 54
Inventory Days 105 108 84 90 82 28 90 83 42 77 80 86
Days Payable 93 86 81 102 71 35 93 102 77 70 57 70
Cash Conversion Cycle 137 57 32 25 49 15 88 76 34 80 78 69
Working Capital Days 125 5 -11 -150 -156 -2 -19 -10 -10 12 -5 28
ROCE % 1% 2% 2% -8% -6% -9% 3% 3% 3% 1% 1% 6%

Insights

In beta
Mar 2015 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
New Patent Applications Filed
Number

Log in to view insights

Please log in to see hidden values.

Login
Patents Granted
Number
Number of Permanent Employees
Number ・Standalone data
Capacity Utilization
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01%
0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
69.95% 69.94% 69.95% 69.95% 69.95% 69.95% 69.95% 69.95% 69.95% 69.94% 69.95% 69.95%
No. of Shareholders 21,69119,87519,18119,11618,78318,24118,49617,58617,04716,51316,06815,824

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings